A beaten-down business with a massive competitive moat is usually a good stock to buy.

Thermo Fisher's strong economic moat, slowing growth, and fair valuation. Valuation is reasonable, trading near decade-low ...

Discover MOAT's balanced, diversified ETF strategy with wide-moat stock selection, downside risk management, and potential ...

Redburn expects Adobe’s free cash flow (FCF) growth to slow to the low single digits by 2030, and now values the stock at 12x ...

Nithin Kamath sees primary competition coming in from first-generation founders who he described as "running, breathing, and ...

A report from CoinGecko has examined the performance of Ethereum (ETH) vs Solana (SOL). The analysis examines various key ...

We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...

We anticipate a prolonged turnaround to delay the global network expansion and expect a lower ultimate store count. We now ...

Park is in solid financial shape from a liquidity and solvency perspective. The company aims to maintain a solid yet flexible balance sheet, which we believe will serve its stakeholders well. Park ...

Zerodha CEO Nithin Kamath believes that Jio Financial Services’ entry into the stockbroking space doesn’t pose as much threat ...

Nakamoto seeks to build the first global network of Bitcoin treasury companies—giving capital markets compliant exposure to ...

Bright Data beat Elon Musk's X and Meta in court, then launched $100M AI infrastructure suite with Deep Lookup and Browser.ai to challenge Big Tech data monopolies.